[8-K] PLAYSTUDIOS, Inc. Reports Material Event

Rhea-AI Filing Summary

PLAYSTUDIOS (MYPS) reported a Nasdaq bid-price deficiency notice. On November 5, 2025, the company was notified that its Class A common stock failed to meet Nasdaq Listing Rule 5450(a)(1) because the closing bid price was below $1.00 for 30 consecutive business days. There is no present impact on trading, and the shares continue on the Nasdaq Global Market under “MYPS.”

The company has 180 calendar days, until May 4, 2026, to regain compliance by achieving a closing bid of at least $1.00 for a minimum of 10 consecutive business days. If not regained by then, PLAYSTUDIOS may seek an additional compliance period by transferring to the Nasdaq Capital Market, which requires a Transfer Application, a $5,000 fee, meeting initial standards (except the minimum bid), and written notice that it intends to cure the deficiency, including via a reverse stock split if necessary.

Insights

Equity markets and listings specialist

Nasdaq bid-price deficiency triggers a defined cure path.

The disclosure states MYPS is below the $1.00 bid threshold for 30 consecutive business days, initiating a standard 180-day cure window. Compliance is straightforwardly defined: the stock must close at or above $1.00 for at least 10 consecutive business days within this period.

If unmet, the company can apply to transfer to the Nasdaq Capital Market by May 4, 2026, pay a $5,000 application fee, meet initial listing criteria (other than bid price), and notify intent to cure, potentially via a reverse stock split. Nasdaq staff will assess the plan; failure could lead to a delisting notice with appeal rights.

Key items are binary: achieving the 10-day price threshold within the 180-day window or proceeding with a transfer and potential reverse split. Actual market impact depends on trading performance and any corporate actions the company undertakes.

0001823878FALSE00018238782025-11-052025-11-050001823878us-gaap:CommonClassAMember2025-11-052025-11-050001823878us-gaap:WarrantMember2025-11-052025-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

November 5, 2025

Date of Report (date of earliest event reported)

PLAYSTUDIOS, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-39652

88-1802794

(State or other jurisdiction of incorporation or organization)

(Commission File Number)

(I.R.S. Employer Identification No.)

10150 Covington Cross Drive, Las Vegas, Nevada

89144

(Address of Principal Executive Offices)

(Zip Code)

Registrant's telephone number, including area code: (725) 877-7000

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A common stock

MYPS

The Nasdaq Stock Market LLC

Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share

MYPSW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On November 5, 2025, PLAYSTUDIOS, Inc. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its Class A common stock was not in compliance with Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Market, as the closing bid price of the Company’s Class A common stock was less than $1.00 per share for the previous 30 consecutive business days.

The notice has no present impact on the listing of the Company’s securities, and the Company’s Class A common stock continues to trade on the Nasdaq Global Market under the symbol “MYPS.”

Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a period of 180 calendar days, or until May 4, 2026, to regain compliance. To regain compliance, during this 180-day compliance period, the closing bid price of the Company’s Class A common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days.

In the event that the Company does not regain compliance with the Nasdaq Listing Rules prior to the expiration of the 180-day compliance period, the Company may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii) by transferring to the Nasdaq Capital Market. To qualify, the Company must submit a Transfer Application and a $5,000 application fee no later than May 4, 2026, the end of the 180-day compliance period. The Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and provide written notice to Nasdaq of its intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes the Company will be able to cure this deficiency. Should the Nasdaq staff conclude that the Company will not be able to cure the deficiency, or should the Company determine not to submit a Transfer Application or make the required representation, Nasdaq will provide notice that the Company’s shares of Class A common stock will be subject to delisting.

If the Company does not regain compliance within the allotted compliance period(s), Nasdaq will provide notice that the Company’s shares of Class A common stock will be subject to delisting. At such time, the Company may appeal the delisting determination to a Hearings Panel. The Company intends to actively monitor its minimum bid price of listed securities and, as appropriate, will consider available options to resolve the deficiencies and regain compliance with the Nasdaq Listing Rules, including applying to transfer to the Nasdaq Capital Market or effecting a reverse stock split. There can be no assurance that the Company will be successful in maintaining the listing of its Class A common stock on the Nasdaq Global Market, or, if transferred, on the Nasdaq Capital Market.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 10, 2025

			PLAYSTUDIOS, Inc.
			By:			/s/ Scott Peterson
						Name:			Scott Peterson
						Title:			Chief Financial Officer

FAQ

What did PLAYSTUDIOS (MYPS) disclose in this 8-K?

It received a Nasdaq notice that its Class A common stock is not in compliance with the $1.00 minimum bid requirement after 30 consecutive business days below that level.

Does the notice affect MYPS trading now?

No present impact; MYPS continues to trade on the Nasdaq Global Market under its current ticker.

How can MYPS regain compliance with Nasdaq’s $1.00 bid rule?

During the 180-day period ending May 4, 2026, the closing bid must be at least $1.00 for a minimum of 10 consecutive business days.

What happens if MYPS does not regain compliance by May 4, 2026?

It may apply to transfer to the Nasdaq Capital Market, pay a $5,000 fee, meet initial standards (except bid price), and state its intention to cure, potentially via a reverse stock split.

Could MYPS be delisted?

If compliance is not regained and transfer conditions are not met or accepted, Nasdaq may issue a delisting notice; the company would have appeal rights to a Hearings Panel.

Will MYPS pursue a reverse stock split?

The company states it will consider available options, including effecting a reverse stock split, to resolve the deficiency.